Trial
NCT05375253
Donor Enriched Activated NK Cell Infusion Post Haploidentical Stem Cell Transplant for Refractory Myeloid Malignancies
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
—
Condition
Leukemia
Intervention
Donor Enriched Activated Natural Killer Cell Infusion
Why stopped
PI has left institution and is taking the study with him.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-03